Morning vs evening administration of nebivolol in obese patients with mild-to-moderate hypertension

Trial Profile

Morning vs evening administration of nebivolol in obese patients with mild-to-moderate hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2011

At a glance

  • Drugs Nebivolol (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jun 2011 New trial record
    • 24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top